Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 17 studies | 31% ± 13% | |
astrocyte | 11 studies | 30% ± 15% | |
microglial cell | 11 studies | 25% ± 10% | |
oligodendrocyte precursor cell | 11 studies | 34% ± 16% | |
glutamatergic neuron | 10 studies | 45% ± 25% | |
mast cell | 9 studies | 24% ± 7% | |
GABAergic neuron | 9 studies | 42% ± 21% | |
adipocyte | 9 studies | 28% ± 10% | |
fibroblast | 9 studies | 24% ± 7% | |
pericyte | 8 studies | 25% ± 8% | |
oligodendrocyte | 8 studies | 27% ± 10% | |
interneuron | 6 studies | 46% ± 24% | |
macrophage | 6 studies | 33% ± 8% | |
neuron | 5 studies | 30% ± 8% | |
B cell | 4 studies | 27% ± 3% | |
granule cell | 4 studies | 25% ± 3% | |
retinal ganglion cell | 4 studies | 29% ± 8% | |
epithelial cell | 4 studies | 31% ± 12% | |
monocyte | 4 studies | 20% ± 3% | |
endothelial cell of lymphatic vessel | 4 studies | 28% ± 6% | |
smooth muscle cell | 4 studies | 22% ± 3% | |
naive B cell | 3 studies | 19% ± 3% | |
GABAergic interneuron | 3 studies | 31% ± 4% | |
dendritic cell | 3 studies | 21% ± 5% | |
ciliated cell | 3 studies | 18% ± 2% | |
neural progenitor cell | 3 studies | 20% ± 4% | |
type I pneumocyte | 3 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1931.74 | 1445 / 1445 | 99% | 10.04 | 181 / 183 |
lung | 100% | 2099.93 | 578 / 578 | 98% | 8.44 | 1130 / 1155 |
breast | 100% | 2764.42 | 459 / 459 | 97% | 8.41 | 1088 / 1118 |
ovary | 100% | 1963.74 | 180 / 180 | 95% | 5.30 | 410 / 430 |
uterus | 100% | 2216.09 | 170 / 170 | 95% | 6.95 | 437 / 459 |
brain | 97% | 927.35 | 2555 / 2642 | 97% | 7.32 | 687 / 705 |
thymus | 100% | 1647.88 | 652 / 653 | 93% | 5.45 | 560 / 605 |
stomach | 100% | 1209.14 | 359 / 359 | 92% | 5.00 | 262 / 286 |
bladder | 100% | 2004.33 | 21 / 21 | 90% | 4.92 | 454 / 504 |
pancreas | 94% | 693.89 | 309 / 328 | 96% | 5.58 | 170 / 178 |
prostate | 100% | 1461.32 | 245 / 245 | 88% | 4.48 | 441 / 502 |
intestine | 100% | 1811.26 | 966 / 966 | 86% | 3.85 | 451 / 527 |
kidney | 100% | 1034.38 | 89 / 89 | 85% | 5.53 | 770 / 901 |
skin | 100% | 2170.64 | 1808 / 1809 | 84% | 5.28 | 398 / 472 |
adrenal gland | 100% | 1499.84 | 258 / 258 | 60% | 2.03 | 138 / 230 |
liver | 96% | 648.50 | 218 / 226 | 51% | 1.86 | 209 / 406 |
blood vessel | 100% | 2783.71 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1686.71 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 3141.96 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1385.38 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 1082.90 | 817 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 8.39 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 83% | 4.64 | 24 / 29 |
peripheral blood | 82% | 1439.36 | 758 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 36% | 1.08 | 29 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097009 | Biological process | energy homeostasis |
GO_0001525 | Biological process | angiogenesis |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0035994 | Biological process | response to muscle stretch |
GO_0016242 | Biological process | negative regulation of macroautophagy |
GO_0110053 | Biological process | regulation of actin filament organization |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_2000270 | Biological process | negative regulation of fibroblast apoptotic process |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0043457 | Biological process | regulation of cellular respiration |
GO_0141068 | Biological process | autosome genomic imprinting |
GO_0048009 | Biological process | insulin-like growth factor receptor signaling pathway |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0031295 | Biological process | T cell costimulation |
GO_0043276 | Biological process | anoikis |
GO_0010592 | Biological process | positive regulation of lamellipodium assembly |
GO_0043201 | Biological process | response to L-leucine |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0001889 | Biological process | liver development |
GO_2000811 | Biological process | negative regulation of anoikis |
GO_0001932 | Biological process | regulation of protein phosphorylation |
GO_0040014 | Biological process | regulation of multicellular organism growth |
GO_0014823 | Biological process | response to activity |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0060048 | Biological process | cardiac muscle contraction |
GO_0038084 | Biological process | vascular endothelial growth factor signaling pathway |
GO_0048015 | Biological process | phosphatidylinositol-mediated signaling |
GO_0055119 | Biological process | relaxation of cardiac muscle |
GO_0086003 | Biological process | cardiac muscle cell contraction |
GO_0014870 | Biological process | response to muscle inactivity |
GO_0030168 | Biological process | platelet activation |
GO_0071548 | Biological process | response to dexamethasone |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0001944 | Biological process | vasculature development |
GO_0036092 | Biological process | phosphatidylinositol-3-phosphate biosynthetic process |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_1903544 | Biological process | response to butyrate |
GO_1905477 | Biological process | positive regulation of protein localization to membrane |
GO_0043542 | Biological process | endothelial cell migration |
GO_0071464 | Biological process | cellular response to hydrostatic pressure |
GO_0006909 | Biological process | phagocytosis |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0007173 | Biological process | epidermal growth factor receptor signaling pathway |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0060612 | Biological process | adipose tissue development |
GO_0016310 | Biological process | phosphorylation |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0032008 | Biological process | positive regulation of TOR signaling |
GO_0016477 | Biological process | cell migration |
GO_0006006 | Biological process | glucose metabolic process |
GO_0030835 | Biological process | negative regulation of actin filament depolymerization |
GO_0005886 | Cellular component | plasma membrane |
GO_0005942 | Cellular component | phosphatidylinositol 3-kinase complex |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005943 | Cellular component | phosphatidylinositol 3-kinase complex, class IA |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005944 | Cellular component | phosphatidylinositol 3-kinase complex, class IB |
GO_0030027 | Cellular component | lamellipodium |
GO_0014704 | Cellular component | intercalated disc |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0043560 | Molecular function | insulin receptor substrate binding |
GO_0030295 | Molecular function | protein kinase activator activity |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
GO_0016303 | Molecular function | 1-phosphatidylinositol-3-kinase activity |
GO_0035005 | Molecular function | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046934 | Molecular function | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
Gene name | PIK3CA |
Protein name | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide 3-kinase alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1) phosphatidylinositol-4,5-bisphosphate 3-kinase (EC 2.7.1.153) p110 alpha (EC 2.7.1.153) Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform variant (EC 2.7.1.153) Mutant phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
Synonyms | protein variant |
Description | FUNCTION: Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives at position 3 of the inositol ring to produce 3-phosphoinositides . Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3) . PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Participates in cellular signaling in response to various growth factors. Involved in the activation of AKT1 upon stimulation by receptor tyrosine kinases ligands such as EGF, insulin, IGF1, VEGFA and PDGF. Involved in signaling via insulin-receptor substrate (IRS) proteins. Essential in endothelial cell migration during vascular development through VEGFA signaling, possibly by regulating RhoA activity. Required for lymphatic vasculature development, possibly by binding to RAS and by activation by EGF and FGF2, but not by PDGF. Regulates invadopodia formation through the PDPK1-AKT1 pathway. Participates in cardiomyogenesis in embryonic stem cells through a AKT1 pathway. Participates in vasculogenesis in embryonic stem cells through PDK1 and protein kinase C pathway. In addition to its lipid kinase activity, it displays a serine-protein kinase activity that results in the autophosphorylation of the p85alpha regulatory subunit as well as phosphorylation of other proteins such as 4EBP1, H-Ras, the IL-3 beta c receptor and possibly others . Plays a role in the positive regulation of phagocytosis and pinocytosis (By similarity). . |
Accessions | C9J951 Q4LE51 C9JAM9 ENST00000643187.1 A0A8A2FPJ2 A0A2R8Y2F6 A0A3G2C3N5 A0A2P0XI22 P42336 ENST00000675786.1 ENST00000468036.1 ENST00000477735.1 A0A6Q8PGV1 A0A6B9QKK2 ENST00000263967.4 A0A6Q8PGN9 E2I6G1 ENST00000674622.1 A0A6B9QIS5 |